The use of clinical risk factors enhances the perfomance of BMD in the prediction of hip and osteoporotic fractures in men and women.

J.A. Kanis, A. Oden, O. Johnell, H. Johansson, C. de Laet, J. Brown, P. Burckhardt, C. Cooper, C. Christiansen, S. Cummings, J.A. Eisman, S. Fujiwara, C. Gluer, D. Goltzman, D. Hans, M.A. Krieg, A. La Croix, E. McCloskey, D. Mellstrom, L.J. MeltonH.A. Pols, J. Reeve, K. Sanders, A.M. Schott, A. Silman, D. Torgerson, T.P. van Staa, N.B. Watts, N. Yoshimura

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1033-1046
Number of pages14
JournalOsteoporosis International
Volume18
Publication statusPublished - 2007

Keywords

  • Farmacie/Biofarmaceutische wetenschappen (FARM)
  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this